Skip to main content
OpenTrials

Clinical trial condition

Nervous System Neoplasms

Explore clinical trials studying Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

2,887 public trials 685 recruiting studies
Refine in advanced search Browse all conditions

Nervous System Neoplasms trial results

Completed

Molecular-Guided Therapy for Childhood Cancer

NCT02162732

Conditions
Adenocarcinoma, Brain Diseases, Brain Neoplasms, +65 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
View all 19 locations
View Trial Details
Completed

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

NCT02831959

Conditions
Brain Diseases, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Grandview Medical Center - Cancer Center Birmingham, Alabama, United States
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
View all 128 locations
View Trial Details
Completed

An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD

NCT04201262

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +26 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Fort Collins, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Miami, Florida, United States
View all 41 locations
View Trial Details
Completed

Study of MEK162 for Children With Low-Grade Gliomas

NCT02285439

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +8 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • Children's National Heath Systems Washington D.C., District of Columbia, United States
View all 15 locations
View Trial Details
Completed

Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread

NCT04631029

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +8 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
View Trial Details

Related conditions